{
    "clinical_study": {
        "@rank": "38485", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Intravenous infusion of 0.9% Sodium Chloride 250 ml during induction of anesthesia and before laparoscopic cholecystectomy."
            }, 
            {
                "arm_group_label": "Ampicillin-sulbactam", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous infusion of 3gr ampicillin-sulbactam in 0.9% Sodium Chloride 250 ml during induction of anesthesia and before laparoscopic cholecystectomy."
            }, 
            {
                "arm_group_label": "Ciprofloxacin", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous infusion of 400 mg ciprofloxacin in 0.9% Sodium Chloride 250 ml during induction of anesthesia and before laparoscopic cholecystectomy."
            }
        ], 
        "brief_summary": {
            "textblock": "The trial aims to assess the value of two-regimen antibiotic prophylaxis versus placebo in\n      elective laparoscopic cholecystectomy."
        }, 
        "brief_title": "Antibiotic Prophylaxis in Laparoscopic Cholecystectomy", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cholelithiasis", 
        "condition_browse": {
            "mesh_term": [
                "Cholelithiasis", 
                "Cholecystolithiasis", 
                "Gallstones"
            ]
        }, 
        "detailed_description": {
            "textblock": "All patients enrolled will be submitted to laparoscopic cholecystectomy. The primary aim of\n      the trial will be to assess the role of prophylactic i.v. infusion of ampicillin-sulbactam,\n      ciprofloxacin, and placebo to reduce the rate of surgical site infection."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elective laparoscopic cholecystectomy;\n\n          -  patients suffering from gallbladder stones,chronic cholecystitis, cholesterolosis, or\n             gallbladder polyps.\n\n        Exclusion Criteria:\n\n          -  acute cholecystitis;\n\n          -  acute cholangitis;\n\n          -  acute pancreatitis;\n\n          -  pregnant or lactating women;\n\n          -  antibiotic allergy;\n\n          -  antibiotic therapy within 48 hours to 7 days prior to surgery;\n\n          -  clinically active infection at the moment of surgery;\n\n          -  evidence of common bile duct stones;\n\n          -  contraindications for laparoscopic cholecystectomy;\n\n          -  no other additional procedure;\n\n          -  indication of obligatory antibiotic prophylaxis because the medical   condition was\n             different from biliary disease (immunosuppression, corticoid use, etc).\n\n          -  patients unable to give informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "138", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01888822", 
            "org_study_id": "MarPic63"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ciprofloxacin", 
                "description": "Prophylactic ciprofloxacin infusion before elective laparoscopic cholecystectomy", 
                "intervention_name": "Ciprofloxacin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ampicillin-sulbactam", 
                "description": "Prophylactic ampicillin-sulbactam infusion before elective laparoscopic cholecystectomy", 
                "intervention_name": "Ampicillin-sulbactam", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Prophylactic placebo infusion before elective laparoscopic cholecystectomy", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ampicillin", 
                "Anti-Bacterial Agents", 
                "Sulbactam", 
                "Sultamicillin", 
                "Ciprofloxacin", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Laparoscopic cholecystectomy", 
            "Prophylactic antibiotics"
        ], 
        "lastchanged_date": "June 25, 2013", 
        "location": {
            "contact": {
                "email": "erasmo.spaziani@uniroma1.it", 
                "last_name": "Erasmo Spaziani, MD, PhD", 
                "phone": "+39-0773708759"
            }, 
            "contact_backup": {
                "email": "annalisa.difilippo@alice.it", 
                "last_name": "Annalisa Di Filippo, MD, PhD", 
                "phone": "+39-0773708759"
            }, 
            "facility": {
                "address": {
                    "city": "Terracina", 
                    "country": "Italy", 
                    "state": "Latina", 
                    "zip": "04019"
                }, 
                "name": "Sapienza University of Rome- Polo Pontino"
            }, 
            "investigator": {
                "last_name": "Annalisa Di Filippo, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "3", 
        "official_title": "Ciprofloxacin, Ampicillin-sulbactam and Placebo Prophylaxis in Laparoscopic Cholecystectomy. A Randomized Controlled Study", 
        "overall_contact": {
            "email": "marcellopicchio@libero.it", 
            "last_name": "Marcello Picchio, MD", 
            "phone": "+39-0773695488"
        }, 
        "overall_official": {
            "affiliation": "Sapienza University of Rome", 
            "last_name": "Erasmo Spaziani, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: National Monitoring Centre for Clinical Trials - Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Surgical site infection defined according to the Centre of Disease Control (CDC) classification, recorded as 'yes' or 'no'.", 
            "measure": "Surgical site infection", 
            "safety_issue": "No", 
            "time_frame": "30 days after operation"
        }, 
        "reference": {
            "PMID": "21154360", 
            "citation": "Sanabria A, Dominguez LC, Valdivieso E, Gomez G. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD005265. doi: 10.1002/14651858.CD005265.pub2. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01888822"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Roma La Sapienza", 
            "investigator_full_name": "Erasmo Spaziani", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Extra-abdominal infections defined according to the CDC classification, recorded as 'yes' or 'no'.", 
                "measure": "Extra-abdominal infections", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Adverse events, defined as allergic reactions to antibiotics.", 
                "measure": "Adverse events.", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Quality of life measured with the 36-Item Short Form Health Survey", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }
        ], 
        "source": "University of Roma La Sapienza", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Roma La Sapienza", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}